EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancing Alzheimer’s Disease Modelling by Developing a Refined Biomimetic Brain Microenvironment for Facilitating High-Throughput Screening of Pharmacological Treatment Strategies

Nuraqila Mohd Murshid iD, Nur Fatin Nabilah Mohd Sahardi iD, Suzana Makpol

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms26010241 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Nuraqila Mohd Murshid und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine, Level 17 Preclinical Building, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak,…. Hauptthemen laut MEDLINE: Alzheimer Disease, High-Throughput Screening Assays, Brain, Biomimetics. Die Arbeit nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Malaysia Ministry of Higher Education Fundamental Research Grant Scheme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) poses a significant worldwide health challenge, requiring novel approaches for improved models and treatment development. This comprehensive review emphasises the systematic development and improvement of a biomimetic brain environment to address the shortcomings of existing AD models and enhance the efficiency of screening potential drug treatments. We identify drawbacks in traditional models and emphasise the necessity for more physiologically accurate systems through an in-depth analysis of current literature. This review aims to study the development of an advanced AD model that accurately replicates key AD pathophysiological aspects using cutting-edge biomaterials and microenvironment design. Incorporating biomolecular elements like Tau proteins and beta-amyloid (Aβ) plaques improve the accuracy of illustrating disease mechanisms. The expected results involve creating a solid foundation for high-throughput screening with enhanced scalability, translational significance, and the possibility of speeding up drug discovery. Thus, this review fills the gaps in AD modelling and shows potential for creating precise and efficient drug treatments for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHigh-Throughput Screening AssaysBrainBiomimeticsHumansAnimalsAmyloid beta-Peptidestau ProteinsDisease Models, AnimalDrug Discovery

Stichwörter der Autor:innen

Alzheimer’s diseasebeta-amyloid plaquebiomimetic braintau proteins

Substanzen

Amyloid beta-Peptidestau Proteins

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Medicine, Level 17 Preclinical Building, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Cheras, Kuala Lumpur 56000, Malaysia.
  • Secretariat of Research and Innovation, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Cheras, Kuala Lumpur 56000, Malaysia.

ORCID-Profile: Nuraqila Mohd Murshid, Nur Fatin Nabilah Mohd Sahardi

Förderung

  • Malaysia Ministry of Higher Education Fundamental Research Grant Scheme

Zitieren

APA

Mohd Murshid, N., Mohd Sahardi, N. F. N., & Makpol, S. (2024). Advancing Alzheimer’s Disease Modelling by Developing a Refined Biomimetic Brain Microenvironment for Facilitating High-Throughput Screening of Pharmacological Treatment Strategies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26010241

Vancouver

Mohd Murshid N, Mohd Sahardi NFN, Makpol S. Advancing Alzheimer’s Disease Modelling by Developing a Refined Biomimetic Brain Microenvironment for Facilitating High-Throughput Screening of Pharmacological Treatment Strategies. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms26010241

BibTeX
@article{MohdMurshid2024,
  author = {Mohd Murshid, Nuraqila and Mohd Sahardi, Nur Fatin Nabilah and Makpol, Suzana},
  title = {Advancing Alzheimer’s Disease Modelling by Developing a Refined Biomimetic Brain Microenvironment for Facilitating High-Throughput Screening of Pharmacological Treatment Strategies},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms26010241}
}
Kostenlos starten →